Pharmacy Compounding: Second Draft Of FDA Compliance Guide Coming Soon
Executive Summary
FDA is likely to issue a second draft of its pharmacy compounding compliance policy guide before issuing a final policy
You may also be interested in...
FDA Rx Compounding Policy Follows 1992 Compliance Guide
FDA is returning to the drug compounding policy laid out in a 1992 compliance policy guide in response to a recent Supreme Court decision
Supreme Court Reaffirms Least Restrictive Standard For Ad Controls
The Supreme Court decision overturning restrictions on advertising of compounded drugs suggests that any moves by Congress to control direct-to-consumer advertising will face a close, skeptical review in court
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011